Less Common or 'Weird' Side Effects of Ozempic

Ozempic has become one of the most talked-about drugs on the planet. Originally approved by the FDA to treat type 2 diabetes, semaglutide — the active ingredient in the Ozempic brand — exploded into mainstream culture as a weight-loss phenomenon. As of 2026, millions of people have taken it, and millions more are weighing whether to start.

Most people have heard about the expected Ozempic side effects: nausea, diarrhea, constipation, and stomach pain. But beneath those familiar warnings lies a far stranger list of ways Ozempic can affect your body, face, brain, and eyes. Some of these “weird-feeling” Ozempic side effects are cosmetic annoyances. Others are medically serious. And a few — like losing your desire to drink alcohol — are so surprising that researchers are actively racing to turn them into new treatments.

What Is Ozempic, and Why Does It Have Such Unusual Side Effects?

Ozempic is the brand name for semaglutide, a GLP-1 receptor agonist (glucagon-like peptide-1). It works by mimicking a hormone your body naturally produces in the gastrointestinal tract in response to eating. GLP-1 triggers the release of insulin from the pancreas, slows gastric emptying, and signals to the brain that you are full. In people with type 2 diabetes, this helps regulate blood sugar. In people who are overweight, it drives significant weight loss by suppressing appetite.

GLP-1 receptors exist not just in your gut and pancreas — they are distributed throughout your body, including in the brain, kidneys, eyes, and cardiovascular system. That is why Ozempic has such a surprisingly wide-ranging biological footprint, and why its side effects range from the mundane to the truly bizarre.

1. “Ozempic Face,” “Ozempic Butt,” “Ozempic Feet,” and “Ozempic Mouth”

Let’s start with the weird Ozempic side effects that have taken social media by storm, because they are perhaps the most visually jarring.

As millions of people lose weight rapidly on GLP-1 medications, a collection of unflattering nicknames has entered the cultural lexicon: “Ozempic face,” “Ozempic butt,” “Ozempic feet,” and “Ozempic mouth.”

Ozempic face refers to the hollowing of the face, increased wrinkles, and a gaunt, prematurely aged appearance that emerges as fat disappears from the cheeks and temples faster than the skin can retract. Ozempic butt describes sagging skin around the buttocks when fat in the area vanishes. Ozempic feet — one of the more unusual entries on this list — results in excessively wrinkled, almost deflated-looking feet. Ozempic mouth causes wrinkles around the lips, sunken cheeks, and sagging jowls.

Doctors clarify that these effects are not caused directly by the drug’s chemistry. Rather, they are byproducts of rapid, substantial weight loss — the kind that happens too quickly for skin to elastically follow. The faster pace of weight loss with GLP-1 drugs makes these changes more dramatic and visible than those from gradual dieting.

2. Stomach Paralysis (Gastroparesis)

One of the more alarming rare Ozempic side effects is a condition called gastroparesis — clinically, “stomach paralysis.” The muscle contractions in the stomach become so weak that the stomach cannot adequately digest food or push it forward into the small intestine. Food sits in the stomach far too long. In some cases, whole undigested pieces of food make their way into the intestines, causing pain and difficult bowel movements.

Symptoms include bloating, nausea, feeling full quickly, heartburn, and stomach cramping. Left untreated, gastroparesis can lead to malnutrition, severe dehydration, and dangerous bowel blockages.

This side effect prompted multiple FDA label updates. In January 2025, the FDA explicitly added language to Ozempic’s label stating the drug is not recommended for patients with severe gastroparesis. In October 2025, the FDA updated the label again to highlight broader risks of serious stomach and pancreatic problems. Reports of related intestinal obstruction (ileus) — a condition in which the bowel stops moving entirely — have also been added to FDA warnings.

As of May 2026, more than 3,600 active lawsuits are pending in a U.S. multidistrict litigation, many of which center on gastroparesis and intestinal obstruction claims. For most patients, this side effect does not occur. But the risk is real enough that persistent bloating, nausea, or stomach pain that does not resolve warrants prompt medical attention.

3. Losing Your Desire to Drink Alcohol — and Other Addictions

Many patients report a dramatic and unexpected reduction in cravings for alcohol, nicotine, and even compulsive behaviors like gambling — not because they tried to quit, but because the desire simply evaporated.

The mechanism involves the brain’s reward centers. GLP-1 receptors exist in the brain, and semaglutide appears to dampen the dopamine surge that rewards pleasurable behaviors.

This is not just an anecdote. A randomized, placebo-controlled clinical trial published in JAMA Psychiatry confirmed the phenomenon: weekly injections of semaglutide significantly reduced alcohol craving, drinking quantity, and the frequency of heavy drinking days in adults with symptoms of alcohol use disorder. A large population study using Swedish health records found that people with alcohol use disorder prescribed semaglutide had a substantially lower risk of hospitalization due to their drinking. Participants in the semaglutide group also reported a steeper drop in daily cigarette use compared to those on placebo.

A Virginia Tech study published in Scientific Reports offered a mechanical explanation: GLP-1 drugs appear to slow the rate at which alcohol enters the bloodstream, which in turn slows its effects on the brain. The reinforcing rush of intoxication simply arrives more slowly and more weakly, reducing its behavioral pull.

An estimated 178,000 U.S. deaths per year are attributed to alcohol. Current FDA-approved medications for alcohol use disorder are widely underused. Ozempic stumbled into this territory as a side effect, and researchers are now actively pursuing clinical trials to establish whether semaglutide could be formally approved as an addiction treatment.

Beyond alcohol, patients have reported reduced cravings for nicotine, gambling, compulsive shopping, and even nail-biting. While the research on these behaviors is less developed than the alcohol data, the dopamine-dampening mechanism offers a plausible explanation for all of them.

4. Hair Loss

Hair loss is not officially listed as an Ozempic side effect by the FDA — and yet it is a reality for a significant number of patients, with reports in scientific literature continuing to grow. The FDA’s Adverse Event Monitoring System had recorded 659 reports of alopecia (hair loss) linked to Ozempic as of early 2026.

In clinical trials for Wegovy, the higher-dose version of semaglutide approved for weight loss, 3% of adults and 4% of children aged 12 and older reported hair loss. A 2025 study found that hair loss was more common in patients on semaglutide than on bupropion-naltrexone, another weight-loss medication, and was more prevalent in women than in men.

The prevailing explanation is indirect: Rapid weight loss can trigger a condition called telogen effluvium, in which large numbers of hair follicles shift simultaneously from a growth phase into a resting phase, causing diffuse shedding that typically begins two to four months after the stressful physiological trigger. Reduced appetite can also inadvertently cut intake of protein, iron, zinc, and biotin — all nutrients essential for healthy hair.

The good news is that for most patients, hair regrows within six to twelve months, especially when nutritional deficiencies are identified and addressed. Doctors often recommend increasing protein intake and considering supplements such as biotin, iron, zinc, and B vitamins when hair shedding related to semaglutide occurs.

5. Sudden Vision Loss (NAION)

A landmark 2024 study published in JAMA Ophthalmology reported that patients with type 2 diabetes or who were overweight and took semaglutide had a significantly higher risk of developing non-arteritic anterior ischemic optic neuropathy (NAION) — a rare condition in which blood flow to the optic nerve is interrupted, potentially causing sudden and irreversible vision loss.

Regulators worldwide took notice. In June 2025, the World Health Organization issued a safety warning advising that semaglutide drugs — including Ozempic, Wegovy, and Rybelsus — may rarely cause NAION, and recommended that doctors discontinue treatment if the condition is confirmed. The European Medicines Agency reached a similar conclusion weeks earlier. Danish health authorities investigated registry data from 44,517 diabetic patients who received Ozempic between 2018 and 2024.

Researchers believe GLP-1 drugs may affect blood flow to the optic nerve, though the exact mechanism is still under investigation. As of May 2026, the FDA has not yet required an NAION warning on Ozempic’s U.S. label. But with thousands of active lawsuits specifically involving Ozempic-related vision loss, this is an area of intense regulatory and legal scrutiny.

6. Muscle Loss (Sarcopenia)

While losing fat is the goal, clinical data show that semaglutide can also cause the body to break down muscle tissue.

In the STEP-1 clinical trial of semaglutide at 2.4 mg over 68 weeks, lean body mass decreased by approximately 6.92 kg — meaning roughly 45% of total weight lost came from lean tissue rather than pure fat. This exceeded what researchers call the “quarter fat-free mass rule,” which predicts that only about one-quarter of weight loss typically comes from lean tissue.

The SEMALEAN study, published in 2025, tracked 115 semaglutide patients over 12 months using DEXA scans. Lean mass initially dropped by about 3 kg at 7 months, then stabilized, while fat mass continued to decline throughout the study period. For younger adults who maintain adequate protein intake and do resistance training, the practical impact is manageable — lean-to-fat ratios often improve overall.

For older adults, the concern is more urgent. A 2025 retrospective cohort study found evidence of accelerated sarcopenia — the age-related loss of skeletal muscle mass and function — particularly at higher semaglutide doses and in individuals who already had low baseline muscle mass. Adults over 65 are already losing 12–16% of their skeletal muscle mass through normal aging; adding rapid weight-loss-driven lean mass loss can push people toward frailty, increased fall risk, and impaired physical function.

Research presented at ENDO 2025 found that women and older adults on semaglutide face a higher risk of muscle loss than younger men. Incorporating resistance training and prioritizing adequate daily protein intake throughout Ozempic treatment are the best-supported strategies for preservation of lean mass.

7. Thyroid Tumors

Ozempic carries a boxed warning — the FDA’s most serious safety designation — for the risk of thyroid C-cell tumors, including a type of cancer called medullary thyroid carcinoma (MTC), and a related hereditary condition called Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).

In animal studies, semaglutide caused thyroid tumors. Whether it causes them in humans is currently unknown — the FDA has not confirmed a causal link in clinical trial data, but the signal was significant enough to warrant the black-box warning. The drug is contraindicated for anyone with a personal or family history of MTC or MEN 2.

Symptoms to watch for include a lump or swelling in the neck, trouble swallowing, hoarseness, or shortness of breath. Anyone on Ozempic who notices these symptoms should contact their healthcare provider immediately.

8. Worsening Diabetic Eye Disease (Retinopathy)

Separate from the NAION risk, some patients with pre-existing diabetic eye disease experience a temporary worsening of diabetic retinopathy shortly after starting Ozempic. The paradox is notable: The drug improves blood sugar levels, yet the rapid normalization of blood glucose can paradoxically stress fragile blood vessels in the retina, worsening an already-compromised condition.

Complications of diabetic retinopathy occur in roughly 3% of patients taking Ozempic. Symptoms include blurry vision, floaters, or other visual changes. This side effect is most relevant for people with pre-existing diabetic eye disease and reinforces why regular eye exams are important for anyone with diabetes starting a new medication.

9. Pancreatitis (Pancreas Inflammation)

Pancreatitis — inflammation of the pancreas — is a rare but potentially serious Ozempic side effect, occurring in less than 1% of patients. It can cause severe, sudden pain in the upper abdomen that radiates to the back, sometimes accompanied by nausea, vomiting, and a rapid heart rate.

In January 2025, the FDA added pancreatitis explicitly to Ozempic’s expanded warning label. The UK’s Medicines and Healthcare Products Regulatory Agency (MHRA) has also initiated a study into the possible link between GLP-1 drugs and acute pancreatitis. Multiple peer-reviewed case reports of acute pancreatitis following semaglutide use have been published in recent years.

Anyone who develops severe upper abdominal pain while taking Ozempic should seek immediate medical attention. If pancreatitis is confirmed, Ozempic is typically discontinued and not restarted. People who have previously had pancreatitis are generally advised against using the drug.

10. Increased Anesthesia Risk During Surgery

Because Ozempic significantly slows gastric emptying, patients taking the drug may have substantially more food and liquid in their stomachs than expected when they arrive for surgery. Under general anesthesia or deep sedation, protective reflexes are suppressed — meaning stomach contents can be aspirated into the lungs, causing a potentially life-threatening condition called pulmonary aspiration.

The FDA officially acknowledged this risk in a November 2024 label update. Medical societies have debated how far in advance patients should stop Ozempic before surgery, with recommendations ranging from one week to multiple weeks depending on dose and individual risk factors.

If you are scheduled for any surgery or procedure requiring anesthesia, tell your surgical team that you take Ozempic. Do not assume they already know or will check.

11. Acute Kidney Injury (Via Dehydration)

Ozempic does not directly damage the kidneys — but it can set off a chain reaction that does. The drug commonly causes nausea, vomiting, and diarrhea, and sustained dehydration from those gastrointestinal effects can contribute to acute kidney injury.

The FDA added explicit warnings about this mechanism to Ozempic’s label in January 2025. Warning signs of kidney stress include swelling, decreased urination, and fatigue. Staying well hydrated — especially in the first several weeks of treatment when GI side effects tend to be most intense — is one of the most important practical steps Ozempic users can take.

The kidney story has an ironic dimension: At appropriate doses in the right patient population, semaglutide actually protects kidney function. The FDA approved Ozempic in 2024 to reduce the risk of worsening kidney disease and cardiovascular death in adults with type 2 diabetes and chronic kidney disease. The same molecule that can injure kidneys via dehydration can, under different circumstances, preserve them metabolically. This paradox captures the complexity of Ozempic as a drug.

12. Injection Site Reactions and Allergic Responses

While rare — occurring in less than 1% of patients in clinical studies — injection site reactions are worth knowing about. Redness, swelling, or localized pain at the injection site can occur. In some cases, patients may develop a more serious allergic reaction, with symptoms including hives, itching, dizziness, difficulty breathing, or swelling of the face, lips, tongue, or throat.

A serious allergic reaction to Ozempic requires emergency medical attention. Patients are advised to rotate injection sites weekly across the abdomen, thigh, and upper arm to reduce local irritation.

How Long Do Ozempic Side Effects Last?

For most gastrointestinal side effects — nausea, bloating, constipation, diarrhea — symptoms typically peak during dose escalation and improve within a few days to weeks as the body adjusts. Some effects can linger for several weeks after stopping the medication, particularly with the highest 2 mg dose.

Cosmetic effects like Ozempic face and hair loss are tied to the pace and degree of weight loss. Hair loss typically appears two to four months after significant weight loss begins and resolves within six to twelve months with proper nutrition. Skin laxity may be more persistent without cosmetic intervention.

Serious side effects like gastroparesis, NAION, or pancreatitis require medical treatment and may not resolve simply with dose reduction or discontinuation.

Who Is Most at Risk for Ozempic Side Effects?

While any patient can experience side effects, certain groups face higher risks for specific unusual reactions:

• Older adults (65+): Higher risk for sarcopenia/muscle loss, frailty, and falls
• People with pre-existing gastroparesis: The drug is now explicitly not recommended for this group
• People with a family history of medullary thyroid carcinoma or MEN 2: Contraindicated entirely
• People with pre-existing diabetic retinopathy: Higher risk for temporary worsening of eye disease
• People with type 2 diabetes who are overweight: Higher observed risk of NAION
• Women: More susceptible to Ozempic-related hair loss than men
• People undergoing surgery: Elevated anesthesia risk that requires advance planning

Ozempic vs. Wegovy, Mounjaro, and Zepbound: Do They All Have These Side Effects?

Many patients ask whether the weird side effects of Ozempic are unique to that specific drug or shared across the broader GLP-1 class.

The short answer: most are shared. Wegovy (higher-dose semaglutide), Mounjaro and Zepbound (tirzepatide), and other GLP-1 drugs carry broadly similar side effect profiles. The cosmetic effects — “Ozempic face,” hair loss — can occur with any drug that causes rapid weight loss. The gastroparesis risk, NAION signal, alcohol craving reduction, and muscle loss concerns apply to the broader GLP-1 medication class.

The nicknames “Ozempic face” and “Ozempic butt” reflect the brand’s cultural dominance more than any unique property of semaglutide. These are essentially rapid-weight-loss phenomena that accompany any GLP-1 medication.

How to Minimize Ozempic Side Effects

Based on current medical research, here are evidence-based strategies to reduce the risk or severity of unusual Ozempic side effects:

Prioritize protein. Aim for 1.2–1.6 grams per kilogram of body weight daily to protect lean muscle mass and support hair health.

Do resistance training. Strength exercise is the most effective known strategy for preserving muscle mass during weight loss on semaglutide.

Stay well hydrated. Dehydration from GI side effects is the main pathway to kidney injury. Consistent fluid intake throughout the day is essential.

Start low and go slow. Gradual dose escalation reduces both GI side effects and the pace of weight loss, which in turn reduces cosmetic effects like skin laxity and hair shedding.

Tell your surgical team. Notify every provider involved in any planned procedure under anesthesia that you take Ozempic. They may recommend stopping it one to two weeks in advance.

Get regular eye exams. If you have diabetes or are overweight and taking semaglutide, annual dilated eye exams are important. Report any sudden changes in vision immediately — this may be a medical emergency.

Monitor for neck changes. Given the thyroid tumor warning, be alert to any lumps, persistent hoarseness, or difficulty swallowing.

Reading This With Health Anxiety — Or When You Actually Need This Drug

If you made it through the sections above and your heart is racing a little, you are not alone. A list of rare but serious side effects — vision loss, stomach paralysis, muscle wasting, thyroid tumors — is genuinely frightening to read, especially if you struggle with health anxiety, or if Ozempic has been prescribed to you because your health actually depends on it.

This section is for you specifically.

First, a Word About Health Anxiety and Medical Information

Health anxiety (sometimes called illness anxiety or, in its more clinical form, somatic symptom disorder) is the tendency to interpret medical information as a personal threat. When you read about a side effect, your brain does not file it under “rare, theoretical, statistical possibility.” It files it under “this is going to happen to me.” Every twinge feels like evidence. Every new symptom feels like confirmation.

Reading about Ozempic side effects with health anxiety can become a loop: You read about gastroparesis, you feel nauseous, the nausea feels like gastroparesis, you read more, you feel worse. This loop is not a character flaw — it is a very understandable response to uncertainty. But it is worth naming, because it can lead people to make decisions that are not actually in their best interest, including stopping a medication that is genuinely helping them.

If you recognize this pattern in yourself, a few grounding thoughts may help before going further.

The side effects described in this article are real, but rare ones are called rare for a reason. NAION, for example, affects a small fraction of Ozempic users — and even within that population, causality has not been definitively established. Gastroparesis severe enough to require hospitalization affects a small minority. Thyroid cancer has not been confirmed in human patients at all. The most common side effects — nausea, constipation, diarrhea — are uncomfortable but manageable for most people, and tend to improve as the body adjusts.

Reading about every possible side effect is not the same as experiencing them. Knowing they exist so you can watch for warning signs is useful. Treating every listed risk as a personal prediction is not.

If You Need Ozempic for Medical Reasons

For many people, Ozempic is not a lifestyle choice — it is a medical necessity. If you have type 2 diabetes and other medications are not controlling your blood sugar, or if your weight-related health conditions, such as heart disease, kidney disease, or sleep apnea, are placing you at serious risk, the calculation around Ozempic is fundamentally different from that of someone taking it primarily for cosmetic weight loss.

When doctors prescribe a medication, they are making a benefit-to-risk calculation on your behalf — and for many patients, the benefits of Ozempic are substantial and well-documented. The drug has been shown to reduce cardiovascular death, lower the risk of kidney disease progression, and significantly improve blood sugar control. For someone with uncontrolled type 2 diabetes, the risks of not treating the condition — blindness from uncontrolled diabetic retinopathy, kidney failure, heart attack, stroke, nerve damage — are typically far greater than the risks listed in any drug’s side effect profile.

If you are taking Ozempic because your doctor determined you need it, the first and most important step is to have a direct conversation about the risks that concern you most. A good prescribing physician will not dismiss your anxiety — they will help you put specific risks in context for your individual situation, your health history, and your existing risk factors.

Some useful questions to bring to that conversation:

• Given my personal health history, which of these side effects am I most at risk for?
• Are there symptoms I should specifically watch for, given my situation?
• What would be the signs that we should reconsider the medication?
• What are the health risks of not taking Ozempic in my case?
• How does my risk of, say, NAION or gastroparesis compare to my risk of the condition you’re treating?

These are not alarmist questions. They are exactly the kind of informed dialogue good medical care is built on.

Managing the Anxiety of Being on a Medication With Risks

Taking any medication that carries real risks — and many do — asks something genuinely difficult of you: holding uncertainty over time. You cannot know in advance whether you will be one of the rare people who develop a serious side effect. What you can do is stay informed, stay in communication with your doctor, and learn to distinguish between symptoms that warrant attention and the normal background noise of living in a body.

A few practical approaches that help:

Designate one trusted source. Rather than Googling symptoms at 2 a.m. and falling into the darkest corner of a medical forum, identify one reliable resource — your doctor, a nurse line, or a reputable medical website — and commit to going there first when you are worried. Restrict how often and when you look up symptoms.

Keep a symptom log instead of catastrophizing in real time. If you notice something that concerns you, write it down with the date, what you were doing, and how long it lasted. Bring the log to your next appointment. This converts abstract anxiety into concrete, communicable information — and often, over time, reveals that the pattern is less alarming than it felt in the moment.

Separate information-gathering from anxiety-spiraling. Reading a comprehensive guide once, with the goal of knowing what to watch for, is useful. Rereading it repeatedly in search of reassurance is anxiety behavior, and it tends to make things worse rather than better. If you find yourself returning to medical content compulsively, that is a signal worth bringing to a therapist or counselor.

Know your actual warning signs. Rather than being vaguely afraid of everything, focus on the specific symptoms that genuinely warrant immediate attention while on Ozempic: sudden changes in vision (call your doctor immediately), severe upper abdominal pain radiating to your back (seek emergency care), a lump or rapidly growing swelling in your neck (see your doctor promptly), and severe dehydration from persistent vomiting or diarrhea (contact your provider). These are clear, actionable signals. Everything else can be discussed at your regular appointments.

Talk to someone. If health anxiety is significantly affecting your quality of life — if fear of side effects is causing you to avoid necessary treatment, or if it is consuming large amounts of your mental energy — that is worth addressing directly. Cognitive behavioral therapy (CBT) has strong evidence behind it for health anxiety specifically, and can help you develop more balanced ways of thinking about medical risk. Your primary care doctor can provide a referral.

The Bigger Picture

The fact that a medication has a long list of possible side effects does not mean it is a bad medication. It often means it is closely studied. Ozempic has been prescribed to millions of people and scrutinized by regulators across multiple continents. The rare risks are known because so many people have taken them, and the data has been gathered carefully.

For most people who take Ozempic as directed under medical supervision, the experience is manageable. GI side effects are common but usually temporary. The serious side effects on this list — NAION, severe gastroparesis, pancreatitis — are rare. They are worth knowing about. They are not worth losing sleep over every night.

Your job is not to eliminate all medical risk from your life — that is not possible. Your job is to make informed decisions alongside your healthcare team, pay attention to how your body responds, know which symptoms actually need urgent attention, and show up to your follow-up appointments. That is enough.

Frequently Asked Questions About Ozempic Side Effects

What is the most unusual side effect of Ozempic? Among the most unexpected is the reduction in alcohol and addiction cravings. Semaglutide acts on dopamine reward pathways in the brain — something not initially anticipated when the drug was developed for diabetes — and multiple clinical trials have now confirmed the effect on alcohol use disorder.

Can Ozempic cause blindness? In rare cases, semaglutide has been associated with NAION, a condition that can cause sudden, irreversible vision loss. The WHO issued a warning about this in June 2025. Any sudden change in vision while taking Ozempic should be treated as a medical emergency.

Does Ozempic cause hair loss? Hair loss is not an officially listed side effect of Ozempic, but many patients report it. It is most commonly caused by telogen effluvium triggered by rapid weight loss, and typically reverses within six to twelve months.

What is Ozempic face? “Ozempic face” describes the gaunt, prematurely aged facial appearance that can result from rapid fat loss in the cheeks and temples. It is a byproduct of rapid weight loss, not a direct chemical effect of semaglutide, and can be addressed through cosmetic procedures if severe.

How long do Ozempic side effects last? Common GI side effects typically improve within a few days to weeks. Hair loss and cosmetic changes may last several months. Serious side effects like gastroparesis or vision loss require medical attention and may not self-resolve.

Does Ozempic cause muscle loss? Yes, clinical trial data show that semaglutide causes some degree of lean mass loss alongside fat loss. In younger adults who exercise and eat adequate protein, the impact is generally manageable. In older adults, the concern is more serious due to the added risk of sarcopenia.